Magnetic Resonance Imaging of the Breast

Seminars in Roentgenology

Volumn 43, Issue 4, 2008, Pages 265-281

  El Khouli, Riham H ^a   Jacobs, Michael A ^a   Bluemke, David A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST DISCHARGE; BREAST EXAMINATION; CANCER RISK; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; HUMAN; IMAGE ANALYSIS; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SIGNAL NOISE RATIO; TREATMENT INDICATION; ULTRASOUND;

ARTIFACTS; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL; CARCINOMA, INTRADUCTAL, NONINFILTRATING; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FIBROADENOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; NEOPLASMS, MULTIPLE PRIMARY; NIPPLES; PAPILLOMA, INTRADUCTAL;

EID: 50549085699     PISSN: 0037198X     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ro.2008.07.002     Document Type: Article

References (70)

1. Vogel P.M., Georgiade N.G., Fetter B.F., et al. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol 104 1 (1981) 23-34
2. Wood C. Computer Aided Detection (CAD) for breast MRI. Technol Cancer Res Treatment 4 1 (2005) 49-53
3. Kuhl C.K., Jost P., Morakkabati N., et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 239 3 (2006) 666-676
4. Rakow-Penner R., Daniel B., Yu H., et al. Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. J Magn Reson Imaging 23 1 (2006) 87-91
5. Rausch D.R., and Hendrick R.E. How to optimize clinical breast MR imaging practices and techniques on your 1.5-T system. Radiographics 26 5 (2006) 1469-1484
6. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 92 1 (2005) 9-15 discussion 15-16
7. Kuhl C.K., Schild H.H., and Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 236 3 (2005) 789-800
8. Nunes L.W., Schnall M.D., and Orel S.G. Update of breast MR imaging architectural interpretation model. Radiology 219 2 (2001) 484-494
9. Schnall M.D., Rosten S., Englander S., et al. A combined architectural and kinetic interpretation model for breast MR images. Acad Radiol 8 7 (2001) 591-597
10. Lee C.H., Smith R.C., Levine J.A., et al. Clinical usefulness of MR imaging of the breast in the evaluation of the problematic mammogram. AJR Am J Roentgenol 173 5 (1999) 1323-1329
11. Morris E.A., Liberman L., Ballon D.J., et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 181 3 (2003) 619-626
12. Tjalma W.A., and Verslegers I.O. Suspicious nipple discharge and breast magnetic resonance imaging. Breast J 10 1 (2004) 65-66 author reply 66
13. Orel S.G., Dougherty C.S., Reynolds C., et al. MR imaging in patients with nipple discharge: initial experience. Radiology 216 1 (2000) 248-254
14. Nakahara H., Namba K., Watanabe R., et al. A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer (Tokyo, Japan) 10 4 (2003) 320-329
15. Jacobs T.W., Connolly J.L., and Schnitt S.J. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?. Am J Surg Pathol 26 9 (2002) 1095-1110
16. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205 2 (1997) 437-440
17. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 212 2 (1999) 543-549
18. Orel S. Who should have breast magnetic resonance imaging evaluation?. J Clin Oncol 26 5 (2008) 703-711
19. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23 33 (2005) 8469-8476
20. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 9473 (2005) 1769-1778
21. Van Goethem M., Schelfout K., Kersschot E., et al. MR mammography is useful in the preoperative locoregional staging of breast carcinomas with extensive intraductal component. Eu J Radiol 62 2 (2007) 273-282
22. Van Goethem M., Schelfout K., Kersschot E., et al. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination. Eur Radiol 14 8 (2004) 1363-1370
23. Van Goethem M., Schelfout K., Dijckmans L., et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 14 5 (2004) 809-816
24. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 14 10 (2004) 1725-1731
25. Rieber A., Brambs H.J., Gabelmann A., et al. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12 7 (2002) 1711-1719
26. Fowler P.A., Casey C.E., Cameron G.G., et al. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging. Br J Obstetr Gynaecol 97 7 (1990) 595-602
27. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 215 1 (2000) 267-279
28. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 292 22 (2004) 2735-2742
29. Liberman L., Morris E.A., Lee M.J., et al. Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179 1 (2002) 171-178
30. Nunes L.W., Schnall M.D., Siegelman E.S., et al. Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast. AJR Am J Roentgenol 169 2 (1997) 409-415
31. Morakkabati-Spitz N., Leutner C., Schild H., et al. Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 15 9 (2005) 2010-2017
32. Forbes F., Peyrard N., Fraley C., et al. Model-based region-of-interest selection in dynamic breast MRI. J Comput Assist Tomogr 30 4 (2006) 675-687
33. Kaiser W.A., and Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170 3 Pt. 1 (1989) 681-686
34. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 211 1 (1999) 101-110
35. Englander S.A., Ulug A.M., Brem R., et al. Diffusion imaging of human breast. NMR Biomed 10 7 (1997) 348-352
36. Park M.J., Cha E.S., Kang B.J., et al. The role of diffusion-weighted imaging and the apparent diffusion coefficient (ADC) values for breast tumors. Korean J Radiol 8 5 (2007) 390-396
37. Wenkel E., Geppert C., Schulz-Wendtland R., et al. Diffusion weighted imaging in breast MRI: comparison of two different pulse sequences. Acad Radiol 14 9 (2007) 1077-1083
38. Rubesova E., Grell A.S., De Maertelaer V., et al. Quantitative diffusion imaging in breast cancer: a clinical prospective study. J Magn Reson Imaging 24 2 (2006) 319-324
39. Yoshikawa M.I., Ohsumi S., Sugata S., et al. Comparison of breast cancer detection by diffusion-weighted magnetic resonance imaging and mammography. Radiat Med 25 5 (2007) 218-223
40. Woodhams R., Matsunaga K., Iwabuchi K., et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 29 5 (2005) 644-649
41. Woodhams R., Matsunaga K., Kan S., et al. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci 4 1 (2005) 35-42
42. Kvistad K.A., Bakken I.J., Gribbestad I.S., et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 10 2 (1999) 159-164
43. Jacobs M.A., Barker P.B., Bottomley P.A., et al. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19 1 (2004) 68-75
44. Jacobs M.A., Ouwerkerk R., Wolff A.C., et al. Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treatment 3 6 (2004) 543-550
45. Jacobs M.A., Barker P.B., Argani P., et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 21 1 (2005) 23-28
46. Hu J., Vartanian S.A., Xuan Y., et al. An improved 1H magnetic resonance spectroscopic imaging technique for the human breast: preliminary results. Magn Reson Imaging 23 4 (2005) 571-576
47. Bakken I.J., Gribbestad I.S., Singstad T.E., et al. External standard method for the in vivo quantification of choline-containing compounds in breast tumors by proton MR spectroscopy at 1.5 Tesla. Magn Reson Med 46 1 (2001) 189-192
48. Bolan P.J., Meisamy S., Baker E.H., et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 50 6 (2003) 1134-1143
49. Pediconi F., Catalano C., Venditti F., et al. Color-coded automated signal intensity curves for detection and characterization of breast lesions: preliminary evaluation of a new software package for integrated magnetic resonance-based breast imaging. Invest Radiol 40 7 (2005) 448-457
50. Lehman C.D., Peacock S., DeMartini W.B., et al. A new automated software system to evaluate breast MR examinations: improved specificity without decreased sensitivity. AJR Am J Roentgenol 187 1 (2006) 51-56
51. Hauth E.A., Jaeger H., Maderwald S., et al. Evaluation of quantitative parametric analysis for characterization of breast lesions in contrast-enhanced MR mammography. Eur Radiol 16 12 (2006) 2834-2841
52. Williams T.C., DeMartini W.B., Partridge S.C., et al. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Radiology 244 1 (2007) 94-103
53. Rieber A., Merkle E., Bohm W., et al. MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Computer Assist Tomogr 21 5 (1997) 773-779
54. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 3 (1999) 881-888
55. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 8 3 (2002) 145-148
56. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 180 2 (2003) 333-341
57. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 226 3 (2003) 773-778
58. Viehweg P., Rotter K., Laniado M., et al. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol Mar 14 3 (2004) 402-408
59. Wiener J.I., Schilling K.J., Adami C., et al. Assessment of suspected breast cancer by MRI: a prospective clinical trial using a combined kinetic and morphologic analysis. AJR Am J Roentgenol 184 3 (2005) 878-886
60. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. New Engl J Med 356 13 (2007) 1295-1303
61. Sinha S., Lucas-Quesada F.A., Sinha U., et al. In vivo diffusion-weighted MRI of the breast: potential for lesion characterization. J Magn Reson Imaging 15 6 (2002) 693-704
62. Guo Y., Cai Y.Q., Cai Z.L., et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 16 2 (2002) 172-178
63. Roebuck J.R., Cecil K.M., Schnall M.D., et al. Human breast lesions: characterization with proton MR spectroscopy. Radiology 209 1 (1998) 269-275
64. Meisamy S., Bolan P.J., Baker E.H., et al. Adding in vivo quantitative 1H MR spectroscopy to improve diagnostic accuracy of breast MR imaging: preliminary results of observer performance study at 4.0 T. Radiology 236 2 (2005) 465-475
65. Baik H.M., Su M.Y., Yu H., et al. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. Magma (New York, NY) 19 2 (2006) 96-104
66. Perlet C., Heinig A., Prat X., et al. Multicenter study for the evaluation of a dedicated biopsy device for MR-guided vacuum biopsy of the breast. Eu Radiol 12 6 (2002) 1463-1470
67. Liberman L., Morris E.A., Dershaw D.D., et al. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. AJR Am J Roentgenol 181 5 (2003) 1283-1293
68. Lehman C.D., Deperi E.R., Peacock S., et al. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR Am J Roentgenol 184 6 (2005) 1782-1787
69. Liberman L., Bracero N., Morris E., et al. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol 185 1 (2005) 183-193
70. Orel S.G., Rosen M., Mies C., et al. MR imaging-guided 9-gauge vacuum-assisted core-needle breast biopsy: initial experience. Radiology 38 1 (2006) 54-61